Implications of preclinical Alzheimer's disease biomarker disclosure for US policy and society
暂无分享,去创建一个
L. Clark | N. Chin | E. Largent | C. Gleason | Emily A. Largent | Claire M. Erickson | Fred B Ketchum | C. Erickson | F. Ketchum
暂无分享,去创建一个
L. Clark | N. Chin | E. Largent | C. Gleason | Emily A. Largent | Claire M. Erickson | Fred B Ketchum | C. Erickson | F. Ketchum